Publication:
Human Papillomavirus, Cytomegalovirus Infection and P16 Staining in Breast Tumors from Peruvian Women

dc.contributor.authorCalderon-Valencia, G
dc.contributor.authorCastaneda-Altamirano, C
dc.contributor.authorCastillo, M
dc.contributor.authorSanchez, J
dc.contributor.authorBernabe, L
dc.contributor.authorSuarez, N
dc.contributor.authorTello, K
dc.contributor.authorTorres, E
dc.contributor.authorCotrina-Concha, JM
dc.contributor.authorDunstan Yataco, J
dc.contributor.authorDe-La-Cruz-Sacasqui, M
dc.contributor.authorAbugattas Saba, J
dc.contributor.authorGuerra Miler, H
dc.contributor.authorManrique Hinojosa, E
dc.contributor.authorAguayo, F
dc.contributor.authorGomez Moreno, HL
dc.date.accessioned2025-01-02T14:42:03Z
dc.date.available2025-01-02T14:42:03Z
dc.date.issued2022
dc.description.abstractObjective: To evaluate the frequency distribution of viral infections in Peruvian Breast Cancer (BC) lesions and its association with clinicopathological features. Additionally, a prospective evaluation of p16 and Tumor-infiltrating lymphocytes (TIL) levels were performed for developing a comprehensive analysis. Methods: Detection of high risk- human papillomavirus (HR- HPV) through qPCR was performed in 447 BC and 79 non-cancer frozen samples. Paired paraffin samples from 238 BC were stained with Human cytomegalovirus (HCMV) and p16 immunohistochemistry. TIL was calculated in 397 BC cases. Results: HCMV was positive in 72.5%. HR- HPV was detected in 2.9% of BC and 1.3% of non-malignant samples. P16+ was found in 28.15% and median TIL percentage was 30. HR- HPV infection was associated with non-ductal histology (p=0.003) and p16+ (p=0.017). Positive P16+ was associated with higher T stage (p=0.022), grade (p=0.009), TIL level (p=0.002), and triple-negative phenotype (p=0.021). Conclusion: HCMV is frequent, but HR- HPV infection is unusual in Peruvian BC. P16+ is associated with HR- PVH infection, high TIL and aggressive features. © 2022. All Rights Reserved.
dc.description.sponsorshipThis study was supported by CONCYTEC, under contracts #204-2015-FONDECYT and #198-2015-FONDECYT.
dc.formatapplication/pdf
dc.identifier.doi10.31557/APJCP.2022.23.5.1571
dc.identifier.journalAsian Pacific Journal of Cancer Prevention
dc.identifier.urihttps://hdl.handle.net/20.500.14703/264
dc.language.isoeng
dc.publisherAsian Pacific Organization for Cancer Prevention
dc.publisher.countryTH
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectHuman papillomavirus- cytomegalovirus- p16 protein- polymerase chain reaction-immunohistochemistry
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.21
dc.titleHuman Papillomavirus, Cytomegalovirus Infection and P16 Staining in Breast Tumors from Peruvian Women
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Files